|
|
|
|
| LEADER |
01607nam a2200337 u 4500 |
| 001 |
EB001999352 |
| 003 |
EBX01000000000000001162253 |
| 005 |
00000000000000.0 |
| 007 |
tu||||||||||||||||||||| |
| 008 |
210907 r ||| eng |
| 020 |
|
|
|a 1587630826
|
| 020 |
|
|
|a 9781587630828
|
| 100 |
1 |
|
|a Coulter, Ian D.
|
| 245 |
0 |
0 |
|a Best-case series for the use of immuno-augmentation therapy and naltrexone for the treatment of cancer
|h Elektronische Ressource
|c prepared for Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services ; prepared by Southern California-RAND Evidence-based Practice Center ; principal investigators, Ian D. Coulter, Mary Hardy
|
| 260 |
|
|
|a [Rockville, MD] : U.S. Dept. of Health and Human Services, Public Health Service, Agency for Healthcare Research and Quality
|c 2003, [2003]
|
| 300 |
|
|
|a viii, 358 p.
|b forms
|c 28 cm
|
| 505 |
0 |
|
|a Includes bibliographical references (p. 127-128)
|
| 653 |
|
|
|a Neoplasms / therapy
|
| 653 |
|
|
|a Immunotherapy / methods
|
| 653 |
|
|
|a Naltrexone / therapeutic use
|
| 653 |
|
|
|a Treatment Outcome
|
| 653 |
|
|
|a Complementary Therapies
|
| 700 |
1 |
|
|a Hardy, Mary L.
|
| 710 |
2 |
|
|a United States
|b Agency for Healthcare Research and Quality
|
| 710 |
2 |
|
|a Southern California Evidence-Based Practice Center/RAND.
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b NCBI
|a National Center for Biotechnology Information
|
| 490 |
0 |
|
|a Evidence report/technology assessment
|
| 500 |
|
|
|a "April 2003."
|
| 856 |
4 |
0 |
|u https://www.ncbi.nlm.nih.gov/books/NBK36952
|3 Volltext
|n NLM Bookshelf Books
|3 Volltext
|
| 082 |
0 |
|
|a 610
|